Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Pemetrexed Disodium Patent Expiration

Pemetrexed Disodium was first introduced by Eli Lilly And Co in its drug Alimta on Feb 4, 2004. Other drugs containing Pemetrexed Disodium are Pemetrexed Disodium, Pemetrexed. 21 different companies have introduced drugs containing Pemetrexed Disodium.


Pemetrexed Disodium Patents

Given below is the list of patents protecting Pemetrexed Disodium, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Pemetrexed US11147817 Pharmaceutical composition of pemetrexed Mar 26, 2035 Shilpa
Alimta US7772209

(Pediatric)

 Antifolate combination therapies May 24, 2022

(Expired)

 Lilly
Alimta US7772209 Antifolate combination therapies Nov 24, 2021

(Expired)

 Lilly
Alimta US5344932

(Pediatric)

 N-(pyrrolo(2,3-d)pyrimidin-3-ylacyl)-glutamic acid derivatives Jan 24, 2017

(Expired)

 Lilly
Alimta US5344932 N-(pyrrolo(2,3-d)pyrimidin-3-ylacyl)-glutamic acid derivatives Jul 24, 2016

(Expired)

 Lilly



Pemetrexed Disodium's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Pemetrexed Disodium Generic API Manufacturers

Several generic applications have been filed for Pemetrexed Disodium. The first generic version for Pemetrexed Disodium was by Fresenius Kabi Usa Llc and was approved on May 25, 2022. And the latest generic version is by Hetero Labs Ltd Unit Vi and was approved on Jun 14, 2024.

Given below is the list of companies who have filed for Pemetrexed Disodium generic, along with the locations of their manufacturing plants worldwide.


1. ACCORD HLTHCARE

Accord Healthcare Inc has filed for 3 different strengths of generic version for Pemetrexed Disodium. Given below are the details of the strengths of this generic introduced by Accord Hlthcare.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE/VIAL

powder Prescription INTRAVENOUS AP May 25, 2022
EQ 500MG BASE/VIAL

powder Prescription INTRAVENOUS AP May 25, 2022
EQ 1GM BASE/VIAL

powder Prescription INTRAVENOUS AP May 25, 2022





2. AMNEAL

Amneal Eu Ltd has filed for 2 different strengths of generic version for Pemetrexed Disodium. Given below are the details of the strengths of this generic introduced by Amneal.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 500MG BASE/VIAL

powder Discontinued INTRAVENOUS N/A Aug 4, 2022
EQ 100MG BASE/VIAL

powder Discontinued INTRAVENOUS N/A May 8, 2023


Manufacturing Plant Locations
New

Amneal's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Amneal as present at those locations.

Country City Firm Name
United States
East Hanover Amneal Pharmaceuticals LLC
Glasgow Amneal Pharmaceuticals LLC
Branchburg Amneal Pharmaceuticals, LLC
Bridgewater Amneal Complex Products Research LLC
Paterson Amneal Pharmaceuticals, Llc
Piscataway Amneal Pharmaceuticals, LLC
Brookhaven Amneal Pharmaceuticals of New York, LLC
Hauppauge Amneal Pharmaceuticals of New York, LLC
India
Hyderabad Amneal Oncology Private Limited
Matoda Amneal Pharmaceuticals Private Ltd.
Ahmedabad Amneal Pharmaceuticals Private Ltd.
Tal Bavla, Ahmedabad Amneal Pharmaceuticals Pvt. Ltd.





3. APOTEX

Apotex Inc has filed for 4 different strengths of generic version for Pemetrexed Disodium. Given below are the details of the strengths of this generic introduced by Apotex.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE/VIAL

powder Prescription INTRAVENOUS AP May 25, 2022
EQ 500MG BASE/VIAL

powder Prescription INTRAVENOUS AP May 25, 2022
EQ 1GM BASE/VIAL

powder Prescription INTRAVENOUS AP May 25, 2022
EQ 750MG BASE/VIAL

powder Prescription INTRAVENOUS AP May 25, 2022


Manufacturing Plant Locations
New

Apotex's manufacturing plants are situated in 3 countries - United States, Canada, India. Given below are the details of these plant locations as well as the firm names of Apotex as present at those locations.

Country City Firm Name
United States
Weston Apotex Corp.
Canada
Toronto Apotex Inc.
Etobicoke Apotex, Inc.
Richmond Hill Apotex Inc.
Winnipeg Apotex Fermentation Inc.
North York Apotex Inc.
Brantford Apotex Pharmachem Inc.
India
Bangalore Apotex Pharmachem India Pvt Ltd.
Bangalore Apotex Research Private Limited - Bioequivalence Centre
Bengaluru Apotex Research Private Limited





4. BAXTER HLTHCARE CORP

Baxter Healthcare Corp has filed for 2 different strengths of generic version for Pemetrexed Disodium. Given below are the details of the strengths of this generic introduced by Baxter Hlthcare Corp.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 500MG BASE/VIAL

powder Discontinued INTRAVENOUS N/A Aug 18, 2022
EQ 100MG BASE/VIAL

powder Discontinued INTRAVENOUS N/A Aug 18, 2022





5. BIOCON PHARMA

Biocon Pharma Ltd has filed for 1 generic for Pemetrexed Disodium. Given below are the details of the strengths of this generic introduced by Biocon Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 1GM BASE/VIAL

powder Discontinued INTRAVENOUS N/A May 25, 2022


Manufacturing Plant Locations
New

Biocon Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Biocon Pharma as present at those locations.

Country City Firm Name
India
Bengaluru Biocon Pharma Limited





6. DR REDDYS

Dr Reddys Laboratories Ltd has filed for 3 different strengths of generic version for Pemetrexed Disodium. Given below are the details of the strengths of this generic introduced by Dr Reddys.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE/VIAL

powder Prescription INTRAVENOUS AP May 25, 2022
EQ 500MG BASE/VIAL

powder Prescription INTRAVENOUS AP May 25, 2022
EQ 1GM BASE/VIAL

powder Prescription INTRAVENOUS AP May 25, 2022





7. EUGIA PHARMA

Eugia Pharma Specialities Ltd has filed for 3 different strengths of generic version for Pemetrexed Disodium. Given below are the details of the strengths of this generic introduced by Eugia Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE/VIAL

powder Prescription INTRAVENOUS AP May 25, 2022
EQ 500MG BASE/VIAL

powder Prescription INTRAVENOUS AP May 25, 2022
EQ 1GM BASE/VIAL

powder Prescription INTRAVENOUS AP May 25, 2022


Manufacturing Plant Locations
New

Eugia Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Eugia Pharma as present at those locations.

Country City Firm Name
India
Riico Industrial Area EUGIA Pharma Specialities Limited
Medchal-Malkajgiri District EUGIA Pharma Specialities Limited
Pashamylaram Eugia Pharma Specialities Limited





8. FRESENIUS KABI USA

Fresenius Kabi Usa Llc has filed for 4 different strengths of generic version for Pemetrexed Disodium. Given below are the details of the strengths of this generic introduced by Fresenius Kabi Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 500MG BASE/VIAL

powder Prescription INTRAVENOUS AP May 25, 2022
EQ 750MG BASE/VIAL

(reference standard)

powder Prescription INTRAVENOUS AP May 25, 2022
EQ 1GM BASE/VIAL

(reference standard)

powder Prescription INTRAVENOUS AP May 25, 2022
EQ 100MG BASE/VIAL

powder Prescription INTRAVENOUS AP May 25, 2022


Manufacturing Plant Locations
New

Fresenius Kabi Usa's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Fresenius Kabi Usa as present at those locations.

Country City Firm Name
United States
Wilson Fresenius Kabi USA, LLC
Grand Island Fresenius Kabi USA, LLC
Melrose Park Fresenius Kabi USA LLC
North Andover Fresenius Kabi USA, LLC
Bensenville Fresenius Kabi USA LLC (FK USA)
Lake Zurich Fresenius Kabi USA, LLC
Melrose Park Fresenius Kabi USA, LLC
Skokie Fresenius Kabi USA LLC





9. HETERO LABS LTD VI

Hetero Labs Ltd Unit Vi has filed for 2 different strengths of generic version for Pemetrexed Disodium. Given below are the details of the strengths of this generic introduced by Hetero Labs Ltd Vi.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 500MG BASE/VIAL

powder Prescription INTRAVENOUS AP Jun 14, 2024
EQ 100MG BASE/VIAL

powder Prescription INTRAVENOUS AP Jun 14, 2024





10. HOSPIRA

Hospira Inc has filed for 3 different strengths of generic version for Pemetrexed Disodium. Given below are the details of the strengths of this generic introduced by Hospira.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE/VIAL

powder Discontinued INTRAVENOUS N/A May 25, 2022
EQ 500MG BASE/VIAL

powder Discontinued INTRAVENOUS N/A May 25, 2022
EQ 1GM BASE/VIAL

powder Discontinued INTRAVENOUS N/A May 25, 2022


Manufacturing Plant Locations
New

Hospira's manufacturing plants are situated in 3 countries - Australia, United States, Dominican Republic (the). Given below are the details of these plant locations as well as the firm names of Hospira as present at those locations.

Country City Firm Name
Australia
Mulgrave Hospira Australia Pty Ltd.
United States
Rocky Mount Hospira, Inc.
Pleasant Prairie Hospira Worldwide, LLC d.b.a. Hospira, a Pfizer-owned Company
Mcpherson Hospira, Inc., A Pfizer Company
Lake Forest Hospira Inc
Morgan Hill Hospira Inc
Clayton Hospira, Inc.
Dominican Republic (the)
Haina, San Cristobal Hospira, Ltd.





11. JIANGSU HANSOH PHARM

Jiangsu Hansoh Pharmaceutical Group Co Ltd has filed for 2 different strengths of generic version for Pemetrexed Disodium. Given below are the details of the strengths of this generic introduced by Jiangsu Hansoh Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE/VIAL

powder Prescription INTRAVENOUS AP May 25, 2022
EQ 500MG BASE/VIAL

powder Prescription INTRAVENOUS AP May 25, 2022


Manufacturing Plant Locations
New

Jiangsu Hansoh Pharm's manufacturing plants are situated in 1 country - China. Given below are the details of these plant locations as well as the firm names of Jiangsu Hansoh Pharm as present at those locations.

Country City Firm Name
China
Lianyungang Jiangsu Hansoh Pharmaceutical Group Co., Ltd
Lianyungang Jiangsu Hansoh Pharmaceutical Group Co., Ltd.





12. MEITHEAL

Meitheal Pharmaceuticals Inc has filed for 4 different strengths of generic version for Pemetrexed Disodium. Given below are the details of the strengths of this generic introduced by Meitheal.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 500MG BASE/VIAL

powder Prescription INTRAVENOUS AP Dec 13, 2022
EQ 750MG BASE/VIAL

powder Prescription INTRAVENOUS AP Dec 13, 2022
EQ 1GM BASE/VIAL

powder Prescription INTRAVENOUS AP Dec 13, 2022
EQ 100MG BASE/VIAL

powder Prescription INTRAVENOUS AP Dec 13, 2022





13. NANG KUANG PHARM CO

Nang Kuang Pharmaceutical Co Ltd has filed for 2 different strengths of generic version for Pemetrexed Disodium. Given below are the details of the strengths of this generic introduced by Nang Kuang Pharm Co.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE/VIAL

powder Prescription INTRAVENOUS AP May 25, 2022
EQ 500MG BASE/VIAL

powder Prescription INTRAVENOUS AP May 25, 2022





14. NORVIUM BIOSCIENCE

Norvium Bioscience Llc has filed for 1 generic for Pemetrexed Disodium. Given below are the details of the strengths of this generic introduced by Norvium Bioscience.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 500MG BASE/VIAL

powder Discontinued INTRAVENOUS N/A Mar 10, 2023





15. PRINSTON INC

Prinston Pharmaceutical Inc has filed for 1 generic for Pemetrexed Disodium. Given below are the details of the strengths of this generic introduced by Prinston Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE/VIAL

powder Prescription INTRAVENOUS AP Dec 11, 2023





16. QILU PHARM HAINAN

Qilu Pharmaceutical Hainan Co Ltd has filed for 2 different strengths of generic version for Pemetrexed Disodium. Given below are the details of the strengths of this generic introduced by Qilu Pharm Hainan.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE/VIAL

powder Prescription INTRAVENOUS AP May 25, 2022
EQ 500MG BASE/VIAL

powder Prescription INTRAVENOUS AP May 25, 2022





17. RELIANCE LIFE

Reliance Life Sciences Pvt Ltd has filed for 2 different strengths of generic version for Pemetrexed Disodium. Given below are the details of the strengths of this generic introduced by Reliance Life.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE/VIAL

powder Prescription INTRAVENOUS AP May 25, 2022
EQ 500MG BASE/VIAL

powder Prescription INTRAVENOUS AP May 25, 2022


Manufacturing Plant Locations
New

Reliance Life's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Reliance Life as present at those locations.

Country City Firm Name
India
Navi Mumbai Reliance Life Sciences Private Limited





18. ZYDUS PHARMS

Zydus Pharmaceuticals Usa Inc has filed for 3 different strengths of generic version for Pemetrexed Disodium. Given below are the details of the strengths of this generic introduced by Zydus Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE/VIAL

powder Prescription INTRAVENOUS AP May 25, 2022
EQ 500MG BASE/VIAL

powder Prescription INTRAVENOUS AP May 25, 2022
EQ 1GM BASE/VIAL

powder Prescription INTRAVENOUS AP May 25, 2022